Thieme to distribute Manson titles

Share this article:
Thieme Publishers will distribute UK-based Manson Publishing titles in the Americas and India, a portfolio that includes close to 100 medical and veterinary titles.

The deal is a good match for both publishers, said Thieme sales director Ross Lumpkin, since both are “very visual publishers.” Manson's self-assessment color review series, “the best color Q&A prep for the [medical] boards,” per Lumpkin, and its color handbook series focused on specific topics like heart failure and gastroenterology, are popular offerings, he said.

Several Manson titles will be launched in the coming months: Parkinson's Disease, Child Abuse and Neglect–A Diagnostic Guide and Psoriasis, to name three, and other titles will be announced quarterly. A release on the deal describes Manson's approach as “having leading authors—mainly from the US and Europe—create concise text/reference books for professionals and students in medicine and veterinary medicine,” illustrated with photographs and diagrams.

Camille Beck, a spokesperson for Thieme, said the Manson titles do not contain advertising “at this time,” but special run printing is available. “It used to be that a [pharmaceutical] company would have to commit to taking at least 500 books to make a special printing with their logo on the cover and a message to the reader inside,” said Lumpkin, adding that marketers can go as low as 100 copies now. “The major stumbling block is that the pharmaceutical company is in too big a rush, and can't wait for what could take two-to-three months to deliver, so they settle for placing a logo sticker on the cover and inserting a message.”

Although Thieme provides online journal access, the company does not offer online-exclusive subscriptions, and does not publish any digital-only journals. However, Thieme “hopes to change this in the near future,” according to Beck.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"